Month: September 2025

Deployment of Xtract One Gateway Becomes Integral Part of Multi-Level Security Initiative TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been selected by Manor Independent School District (“Manor ISD”) in Manor, Texas to strengthen security efforts. The initial deployment will take place at Manor High School, Manor Early College High School, Manor New Tech High School, and Manor Senior High School, with plans to expand across all the district’s 15 campuses at a later date. This deployment contributes to the multi-tier safety initiative Manor ISD began implementing in Fall 2024. These heightened measures will bolster long-term security processes and operations across the entire district....

BOCA RATON, FL, Sept. 22, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced an LOI for the establishment of DeFi Development Corp. Korea (“DFDV Korea”), a Solana Digital Asset Treasury (“DAT”), through the Company’s Treasury Accelerator program. DFDV Korea will be created through the acquisition of a publicly listed company in Korea. A management team from Fragmetric will lead the new entity, bringing deep experience in Korea’s digital asset markets and institutional channels. As part of the partnership, DeFi Development Corp. established a partnership fee arrangement tied to services such as asset management, accounting/finance support, and technology services, and will receive an equity...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) — FURY GOLD MINES LIMITED (TSX: FURY, NYSE American: FURY) (“Fury” or the “Company”) is pleased to announce that it has entered into an agreement with Haywood Securities Inc., on behalf of itself and a syndicate of agents to be formed (collectively, the “Agents”) pursuant to which the Agents have agreed to sell, on a commercially reasonable efforts agency basis, any combination of: (i) national charity flow-through units (the “Charity FT Units”) at a price per Charity FT Unit of C$1.21; and (ii) traditional flow-through shares (the “Traditional FT Shares”) at a price per Traditional FT Share of C$1.00, for total aggregate gross proceeds of up to C$12,000,000 (the “Offering”).   ...

Infographic 1Infographic 1Infographic 2Infographic 2Infographic 3Infographic 3Infographic 4Infographic 4Infographic 5Infographic 5Infographic 6Infographic 6Infographic 7Infographic 7Visible gold to the naked eye “VG-NE” heat map of all holes reported to date 2021 – 2025 (see below).An accompanying infographic is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/0a12f8b1-aa01-49b0-85d4-7fdb8b347dbfSince drilling started in 2021, many holes have returned impressive metal factors with 9 holes delivering greater than 200 grams*meters (“g*m”) and up to 1346 g*m, 11 holes greater than 150 g*m, 25 holes greater than 100 g*m, 32 holes greater than 75 g*m and 63 holes greater than 50 g*m have been drilled on the Surebet Discovery that remains wide open. Drill...

REYKJAVIK, Iceland, Sept. 22, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) has adopted a positive opinion recommending approval for AVT03, Alvotech’s proposed biosimilar to Prolia® (denosumab 60 mg/mL single use pre-filed syringe) and Xgeva® (denosumab 70 mg/mL single use vial). Pending approval, the biosimilar will be marketed by Alvotech’s commercial partners, STADA Arzneimittel AG (“STADA”) and Dr. Reddy’s Laboratories SA (“Dr. Reddy’s”), each partner with semi-exclusive commercial rights in Europe, including Switzerland and the UK. “We look forward to working with our partners in making denosumab...

REYKJAVIK, ICELAND (September 22, 2024) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) has adopted a positive opinion recommending approval for AVT03, Alvotech’s proposed biosimilar to Prolia® (denosumab 60 mg/mL single use pre-filed syringe) and Xgeva® (denosumab 70 mg/mL single use vial). Pending approval, the biosimilar will be marketed by Alvotech’s commercial partners, STADA Arzneimittel AG (“STADA”) and Dr. Reddy’s Laboratories SA (“Dr. Reddy’s”), each partner with semi-exclusive commercial rights in Europe, including Switzerland and the UK. “We look forward to working with our partners in making denosumab available more...

HONG KONG, Sept. 22, 2025 (GLOBE NEWSWIRE) — GPTBots.ai, the enterprise AI platform of Aurora Mobile (NASDAQ: JG), co-hosted the highly anticipated thematic course “AI Agents Drive Intelligent Transformation” with the Hong Kong Productivity Council (HKPC). The course successfully concluded at the HKPC Building.The event brought together enterprise leaders and AI innovators to delve into digital and intelligent upgrades, systematically analyzing the practical applications of AI Agents across end-to-end business scenarios. It provided Hong Kong enterprises with fresh perspectives and actionable strategies to overcome transformation bottlenecks and embrace cutting-edge AI innovation.(Photo by GPTBots) This training session not only delivered cutting-edge AI technologies and invaluable practical experience to local businesses...

LTA appoints Grab to operate WeRide autonomous vehicles on two designated routes in Punggol, Singapore Ai.R features two WeRide vehicle models: a five-seater GXR and an eight-seater Robobus WeRide marks its first deployment of GXRs in Singapore and Southeast Asia Ai.R vehicles have passed Singapore’s stringent Milestone 1 (M1) assessment, proving they can safely navigate on public roads GrabAcademy and WeRide have started training private-hire and taxi drivers as autonomous vehicle Safety OperatorsSINGAPORE, Sept. 22, 2025 (GLOBE NEWSWIRE) — WeRide (Nasdaq: WRD), a global leader in autonomous driving technology, announced that it will be deploying its GXRs and Robobus vehicles in Singapore as part of Ai.R, Grab’s first autonomous vehicle (AV) service for Singapore consumers. Ai.R, short for Autonomously Intelligent Ride,...